Result 7, "Human Retinoic Acid Receptor . . . " M57707. |
Hanausek-Walaszk et al., "Carcinogenesis," Proceedings of the American Association for Cancer Research 30:190, Abstract 754 (1989). |
Larroya et al., "Immunology," Proceedings of the American Association for Cancer Research 30:349, Abstract 1385 (1989). |
Hanausek-Walaszek et al., "Carcinogenesis," Proceedings of AACR 29:167, Abstract 665 (1988). |
Hanausek-Walaszek et al., "Correspondence Between Biochemical and Antigenic Activity of a 60 Kilodalton Oncofetal Protein During Carcinogenesis and Tumorigenesis," Cancer Letters 33:55-61 (1986). |
Hanausek-Walaszek et al., "A 60 Kilodalton Oncofetal Protein As Tumor Marker," J. Med. 17:13-23 (1986). |
Schroder et al., "Proteins from rat lover cytosol which stimulate mRNA transport," Eur. J. Biochem. 159:51-59 (1986). |
Hanausek-Walaszek et al., "Immunological Identity of a 60 KD Onmcofetal Protein Induced in Rats by Chemical Carcinogens and Released by Transformed Cells," BBRC 127:779-785 (1985). |
Hanusek-Walaszek et al., "Chemical carcinogens as specific inducers of a 60-kilodalton oncofetal protein in rats," Carcinogenesis 7:1725-1730 (1985). |
Schumm et al., "Abscence of the Cancer-Associated Factor with a Molecular Weight of 60,000 from the Plasma of Patients with a Spectrum of Nonneoplastic Conditions," Cancer Res. 44:401-406 (1984). |
Hanausek-Walaszek et al., "Characterization of a 60,000-dalton Oncofetal Protein from the Plasma of Tumor-Bearing Rats," Cancer Invest. 2:433-441 (1984). |
French et al., "Nucleocytoplasmic Release of Repetitive DNA Transcripts in Carcinogenesis Correlates with a 60 Kilodalton Cytoplasmic Protein," Cancer Letters 23:45-52 (1984). |
Walaszek et al., "An Oncofetal 60-Kilodalton Protein in the Plasma of Tumor-Bearing and Carcinogen-Treated Rats," Cancer Letters 20:277-282 (1983). |
Hanausek-Walaszek et al., "Structural and Immunological Identity of p65 Tumor-Associated Factors from Rat and mouse Hepatocarcinomas," Progress in Clinical and Biological Research (1989). |
Mirowski et al., "Purification and Characterization of a 65-kDa Tumor-Associated Phosphoprotein from rat Transplantable Hepatocellular Carcinoma 1682C Cell Line," Protein Exp. and Pur. 3:196-203 (1992). |
Wang et al., "Monoclonal Antibodies Against a 65-kDa Tumor-Associated Phosphoprotein: Development and Use in Cancer Detection," Hybridoma 12:167-176 (1993). |
Mirowski et al., "Demonstration of a 65 kDa Tumor-Specific Phospho-protein in Urine and Serum of Rats with N-methyl-N-nitrosourea-induced Mammary Adenocarcinomas," Carcinogenesis 14:1659-1664 (1993). |
Mirowski et al., "Comparative Structural Analysis of Human and Rat 65 kDa Tumor-Associated Phosphoproteins," Int. J. Biochem. 25:1865-1871 (1993). |
Del Rio et al., "Expression of a 65 kDa Oncofetal Phosphoprotein in the Altered Hepaic Foci of Rats Fed 2-Acetylaminofluorene Followed by Phenobarbital," Int. J. Oncol. 5:259-265 (1994). |
Mirowski et al., "Serological and Immunohistochemical Detection of a 65-kDa Oncofetal Protein in Breast Cancer," European Journal of Cancer 30A:1108-1113 (1994). |
Hanausek et al., "The Oncofetal Protein p65 as a New Member of the Steroid/Thyroid Receptor Superfamily," Cancer Detection and Prevention 19:1995, Abstract 118/307 307 (1995). |
Mirowski et al., "Isolation of the 65 kDa Oncofetal Phosphoprotein from Fetal Bovine Serum, Polyclonal Antibody Production and use in Cancer Detection," AACR (/toronto, Mar. 20, 1995). |
Hanausek et al., "The Oncofetal Protein p65 as a Member of the Steroid/Thyroid Receptor Superfamily: Relevance to Breast Cancer," AACR (Toronto, Mar. 20, 1995). |